What to Know About Infusion Therapy for IBD
The human gastrointestinal tract can be a hostile place for visitors. It’s filled with digestive acids and microorganisms that rapidly break down swallowed bits of food, and it can be just as rough on non-food molecules. That includes some of the latest drugs for the treatment of inflammatory bowel disease (IBD). “Some medications that target the immune system don’t work if they’re swallowed because your gut would digest them like a piece of steak,” says Dr. Gilaad Kaplan, a gastroenterologist, IBD researcher, and professor of medicine at the University of Calgary in Canada. “You have to...
Source: TIME: Health - January 10, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Source Type: news
After disastrous Galapagos deal, Gilead finds new rheumatoid arthritis partner
Gilead is looking for another shot at treating rheumatoid arthritis after its massive Galapagos deal fell flat in the face of an FDA rejection and, more recently, a withdrawn Phase I of another asset for the inflammatory disease. The California biopharma, coming off a…#gilead #gs5718 #nanodisc #googles #finish #danieloday #massivegalapagos #irak4 #evoq #disease (Source: Reuters: Health)
Source: Reuters: Health - January 4, 2023 Category: Consumer Health News Source Type: news
Similar Time to Remission in Late-Onset vs Younger-Onset RA Similar Time to Remission in Late-Onset vs Younger-Onset RA
In this study, patients who developed rheumatoid arthritis later in life were just as likely to reach remission as those with younger-onset disease.Arthritis Research & Therapy (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 30, 2022 Category: Radiology Tags: Rheumatology Journal Article Source Type: news
FDA approves Roche ’s Actemra for the treatment of COVID-19 in hospitalised adults
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19Since the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra worldwideActemra is approved for this use in more than 30 countries for the treatment of COVID-19Basel, 21 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra ® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalised adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasi...
Source: Roche Media News - December 21, 2022 Category: Pharmaceuticals Source Type: news
CAR T Therapy To Treat And Cure Rheumatoid Arthritis
One study progresses towards a cure for rheumatoid arthritis by using CAR T therapy, a treatment originally designed to fight cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 19, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug
Dr Reddy's Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be used in the treatment of rheumatoid arthritis in adults. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2022 Category: Pharmaceuticals Source Type: news
Study shows two foods best for easing arthritis symptoms - and foods to avoid
Of the study participants, 24 percent stated that at least one food had an effect on their rheumatoid arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - December 17, 2022 Category: Consumer Health News Source Type: news
Rheumatoid Arthritis Linked to Peripheral Artery Disease
FRIDAY, Dec. 16, 2022 -- There may be an association between rheumatoid arthritis (RA) and peripheral artery disease (PAD), according to a review published online Nov. 30 in Rheumatology International.
Tayser Zoubi, from Flinders University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 16, 2022 Category: Pharmaceuticals Source Type: news
RA Risk Raised by Work-Related Inhaled Agents RA Risk Raised by Work-Related Inhaled Agents
Exposure to detergents, dusts, and other chemicals in the workplace could be putting genetically susceptible people at risk of rheumatoid arthritis.MDedge News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - December 15, 2022 Category: Primary Care Tags: Rheumatology News Source Type: news
Science ’s 2022 Breakthrough of the Year: A telescope’s golden eye sees the universe anew
html { scroll-behavior: smooth; } .news-article-content--featured>.bodySection>.mb-2x:not(:first-of-type) { display: none; } h3 { scroll-margin-top: 5rem; } .parent-section h3, .subsection h3 { font-size: 1.375rem; line-height: 1.875rem; } .news-article-content-footer h2 { display: none; } .toc img { padding-bottom: 16px; transition: opacity .25s; } .toc img:hover { opacity: 60%; } .toc .image-grid img { padding-bottom: 16px; padding-top: 16px; } .image-grid .news-article__figure__image__wrapper:before, .image-grid .news-article__figure__image__wrapper:after { display: none; } .news-article...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
Bob Mortimer says he 'just woke up' with a 'BANG' - 'It came back'
bob mortimer health rheumatoid arthritis symptoms treatment (Source: Daily Express - Health)
Source: Daily Express - Health - December 14, 2022 Category: Consumer Health News Source Type: news
It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One!
(MedPage Today) -- A novel drug conjugate combining steroidal and tumor necrosis factor (TNF) inhibitor activity appeared highly effective in a phase IIa trial as a treatment for rheumatoid arthritis (RA).
Patients with active RA assigned to the... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 14, 2022 Category: Gastroenterology Source Type: news
N.W.T. no longer offering rheumatology services, patients must travel to Edmonton
An Alberta-based rheumatologist says the N.W.T. health authority is opting to send hundreds of rheumatoid arthritis patients south to Edmonton for treatment, despite efforts to start up a local program in Yellowknife. (Source: CBC | Health)
Source: CBC | Health - December 14, 2022 Category: Consumer Health News Tags: News/Canada/North Source Type: news
Addition of Immunomodulators Cuts Vascular Inflammation in RA
MONDAY, Dec. 12, 2022 -- For patients with rheumatoid arthritis (RA), the addition of a tumor necrosis factor (TNF) inhibitor (TNFi) or addition of sulfasalazine and hydroxychloroquine (triple therapy) to methotrexate results in clinically important... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2022 Category: Pharmaceuticals Source Type: news
Rheumatoid Arthritis Treatment Seen as Substandard for Most Patients
(MedPage Today) -- Clinicians could improve outcomes in their patients with rheumatoid arthritis (RA) by paying attention to certain markers of care quality, such as early referral to certified rheumatologists and prescribing standard drugs for... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 12, 2022 Category: Rheumatology Source Type: news
